About Us
Medical Blog
  • NeuroTronik Closes $23.1 million Series B Round

    NeuroTronik, a North Carolina based subsidiary of NeuroTronik LTD of Dublin, announced that it recently closed a $23.1 million Series B funding round. The press release noted that the round was led by contributions from Boston Scientific, Synergy Life Science Partners, and several venture capital firms.  NeuroTronik was quoted in the release as aiming to improve patient outcomes, shorten hospi ...
  • Medical Device Excise Tax Remains in Limbo

    President Trump and Paul Ryan (R-Wis) have not yet successfully replaced the Affordable Care Act with the American Health Care Act (“AHCA”).  The medical device industry had been paying particular attention to the proposed reform because the 2.3% excise tax that was suspended for 2016 and 2017 is scheduled to go back into effect on January 1, 2018. The tax, which has already required the pa ...
  • Novartis’ Gilenya Patent Invalidated as Obvious

    On April 12, 2017, the Federal Circuit affirmed the determination by the US Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (Board) that the claims of  U.S. Patent No. 8,324,283 (“the ’283 patent”) were invalid as obvious. US Patent No. 8,324,283 According to public databases, Novartis AG is the assignee of the ’283 patent, directed to pharmaceutical compositions ...
Conferences